Fatal Pulmonary Hypertension Associated with Short-Term Use of Fenfluramine and Phentermine
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The dangers inherent in marked obesity have prompted physicians to advocate more aggressive strategies for weight reduction. One current strategy is the prescription of fenfluramine,1,2 either alone or in combination with phentermine, with the knowledge that the risks of the drugs must be balanced against the risks of continued obesity. Pulmonary hypertension in adults has several causes that can be identified pathologically. In the case of pulmonary hypertension that develops with hypoxia during the course of chronic obstructive or interstitial fibrosing disease of the lung, the pulmonary vessels are characterized by intimal and medial hyperplasia and luminal stenosis. Thromboembolic . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Primary Pulmonary Hypertension
Rubin, L. J. (1993) · Chest · doi:10.1378/chest.104.1.236 · Cited by 305
Pathology of Pulmonary Hypertension.
(1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-1-137_3 · Cited by 236
Fenfluramine: A Review of its Pharmacological Properties and Therapeutic Efficacy in Obesity
Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M., & Avery, G. S. (1975) · Drugs · doi:10.2165/00003495-197510040-00001 · Cited by 212
Mette, S. A., Palevsky, H. I., Pietra, G. G., Williams, T. M., Bruder, E., Prestipino, A. J., Patrick, A. M., & Wirth, J. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.5.1196 · Cited by 192
Weintraub, M. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.68 · Cited by 171
Irreversible pulmonary hypertension after treatment with fenfluramine.
McMurray, J. J. V., Bloomfield, P., & Miller, H. (1986) · BMJ · doi:10.1136/bmj.293.6538.51-d · Cited by 72
The histopathology of 36 cases of plexogenic pulmonary arteriopathy
CASLIN, A. W., Heath, D., Madden, B., Yacoub, M. H., Gosney, J. R., & Smith, P. F. (1990) · Histopathology · doi:10.1111/j.1365-2559.1990.tb01054.x · Cited by 61
Primary pulmonary hypertension and human immunodeficiency virus infection in a non-hemophiliac man
Jacques, C., Richmond, G. J., Tierney, L. M., Curtis, J. L., McKerrow, J. H., & Warnock, M. L. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90243-v · Cited by 23
Cited by
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
Pulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,463
2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Primary pulmonary hypertension
Runo, J. R., & Loyd, J. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13167-4 · Cited by 521
Page, R. L., O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. (2016) · Circulation · doi:10.1161/cir.0000000000000426 · Cited by 471
Primary Pulmonary Hypertension: A Vascular Biology and Translational Research “Work in Progress”
Archer, S., & Rich, S. (2000) · Circulation · doi:10.1161/01.cir.102.22.2781 · Cited by 354
Current and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 331
Pulmonary Arterial Hypertension
Chin, K. M., & Rubin, L. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.024 · Cited by 309
YI, E. S., KIM, H., AHN, H., STROTHER, J., MORRIS, T., MASLIAH, E., HANSEN, L. A., PARK, K., & FRIEDMAN, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912131 · Cited by 267
KANEKO, F. T., ARROLIGA, A. C., DWEIK, R. A., COMHAIR, S. A., LASKOWSKI, D., OPPEDISANO, R., THOMASSEN, M. J., & ERZURUM, S. C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9802066 · Cited by 228
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
Humbert, M., Deng, Z., Simonneau, G., Barst, R. J., Sitbon, O., Wolf, M., Cuervo, N., Moore, K. J., Hodge, S. E., Knowles, J. A., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.01762002 · Cited by 211
“However, some patients developed severe PAH even with short-term use of fenfluramine, emphasising the relevance of individual susceptibility to fenfluramines [3, 18].”
BackgroundDopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs
Booij, J., & Kemp, P. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0621-0 · Cited by 175
“The adverse effects that came to be associated with fenfluramine and dexfenfluramine, valvular heart disease and primary pulmonary hypertension [74, 75], have led to their eventual withdrawal from the market in 1997 [76].”
Metadata
- Authors
- Mark, E. J., Patalas, E. D., Chang, H. T., Evans, R. J., & Kessler, S. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1997-08-28
- Volume
- 337
- Issue
- 9
- Pages
- 602-606
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2327192631
- Cited by
- 179
- References
- 11
- FWCI
- 19.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.